These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 9045528

  • 1. [Gastroduodenal tolerance and clinical effectiveness of therapy with lonazolac-calcium in rheumatic diseases].
    Kullich W, Fromme K, Klein G.
    Wien Med Wochenschr; 1996; 146(17):459-64. PubMed ID: 9045528
    [Abstract] [Full Text] [Related]

  • 2. [Changes in the serum pepsinogen level during therapy with acemtacin retard as a measure of gastroduodenal tolerance].
    Kullich W, Klein G.
    Wien Med Wochenschr; 1991; 141(15):331-5. PubMed ID: 1949833
    [Abstract] [Full Text] [Related]

  • 3. [Value of pepsinogen I in serum as a screening method for early detection of gastroduodenal lesions and follow-up in therapy with non-steroidal antirheumatic drugs].
    Kullich W, Pöllmann G, Zmerekar C, Klein G.
    Z Rheumatol; 1991; 50(1):39-45. PubMed ID: 2058321
    [Abstract] [Full Text] [Related]

  • 4. [Determination of serum pepsinogen I and II for assessment of gastroduodenal tolerance of S(+) ibuprofen].
    Kullich W, Wallner H, Klein G.
    Wien Klin Wochenschr; 1994; 106(7):208-11. PubMed ID: 8197755
    [Abstract] [Full Text] [Related]

  • 5. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G, Lazzaroni M, Petrillo M.
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [Abstract] [Full Text] [Related]

  • 6. [Nizatidine in therapy and prevention of non-steroidal anti-rheumatic drug-induced ulcers in rheumatic patients].
    Simon B, Leucht U, Amon I, Brandau J, Müller P.
    Z Gastroenterol; 1993 Jun; 31(6):395-400. PubMed ID: 8212757
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of non-steroidal anti-inflammatory drug-induced damage to gastric mucosa using ranitidine. Comparison of the effectiveness of 2 dosages].
    Müller P, Dammann HG, Marinis E, Weise D, Simon B.
    Fortschr Med; 1989 Oct 30; 107(31):667-70. PubMed ID: 2687142
    [Abstract] [Full Text] [Related]

  • 8. Influence of Helicobacter pylori eradication therapy on the occurrence of gastrointestinal events in patients treated with conventional nonsteroidal antiinflammatory drugs combined with omeprazole.
    Bannwarth B, Dorval E, Caekaert A, Barthelemy P.
    J Rheumatol; 2002 Sep 30; 29(9):1975-80. PubMed ID: 12233895
    [Abstract] [Full Text] [Related]

  • 9. Non steroidal anti-inflammatory drugs. Risk factors versus benefits.
    Savvas P, Brooks PM.
    Aust Fam Physician; 1991 Dec 30; 20(12):1726-9, 1732-3. PubMed ID: 1805774
    [Abstract] [Full Text] [Related]

  • 10. Influence of lornoxicam on serum pepsinogen levels.
    Kullich W, Klein G, Pöllmann G.
    Postgrad Med J; 1990 Dec 30; 66 Suppl 4():S46-8. PubMed ID: 2149454
    [Abstract] [Full Text] [Related]

  • 11. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
    Agréus L, Storskrubb T, Aro P, Ronkainen J, Talley NJ, Sipponen P.
    Scand J Gastroenterol; 2009 Dec 30; 44(5):564-70. PubMed ID: 19263272
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of upper gastrointestinal mucosal abnormalities at a rheumatology clinic.
    Senior J, Rubio C, González Pares E, Torres EA.
    Bol Asoc Med P R; 1988 Jul 30; 80(7):241-4. PubMed ID: 3262351
    [No Abstract] [Full Text] [Related]

  • 13. Clinical experience with lonazolac-calcium in the treatment of osteo-arthritis.
    Dijs H, Verheyen G, Guastavino V, De Vroey T, Deckers K, Driessens M.
    Acta Belg Med Phys; 1990 Jul 30; 13(4):213-5. PubMed ID: 2097865
    [No Abstract] [Full Text] [Related]

  • 14. An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen.
    Lanza FL, Codispoti JR, Nelson EB.
    Am J Gastroenterol; 1998 Jul 30; 93(7):1051-4. PubMed ID: 9672328
    [Abstract] [Full Text] [Related]

  • 15. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC.
    Semin Arthritis Rheum; 2002 Dec 30; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [Abstract] [Full Text] [Related]

  • 16. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
    Koch M.
    Ital J Gastroenterol Hepatol; 1999 Dec 30; 31 Suppl 1():S54-62. PubMed ID: 10379471
    [Abstract] [Full Text] [Related]

  • 17. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Sowers JR, White WB, Pitt B, Whelton A, Simon LS, Winer N, Kivitz A, van Ingen H, Brabant T, Fort JG, Celecoxib Rofecoxib Efficacy and Safety in Comorbidities Evaluation Trial (CRESCENT) Investigators.
    Arch Intern Med; 2005 Jan 24; 165(2):161-8. PubMed ID: 15668361
    [Abstract] [Full Text] [Related]

  • 18. [Endoscopic study of gastroduodenal tolerance in rheumatoid arthritis patients affected by treatment with a substituted phenylalcanoic derivative].
    Mirelli E, Fichera G, Colombo B.
    Minerva Med; 1973 Jan 24; 64(48):2527-31. PubMed ID: 4726745
    [No Abstract] [Full Text] [Related]

  • 19. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
    MMW Fortschr Med; 2004 Apr 08; 146(15):66. PubMed ID: 15373027
    [No Abstract] [Full Text] [Related]

  • 20. [Lesion of the gastroduodenal mucosa caused by non-steroidal anti-inflammatory drugs (NSAID)].
    Pastor García E.
    Aten Primaria; 1990 Jun 08; 7(6):448, 450-1. PubMed ID: 2129719
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.